• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases.

作者信息

Velardo Daniele, Riva Nilo, Del Carro Ubaldo, Bianchi Francesca, Comi Giancarlo, Fazio Raffaella

机构信息

Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.

Division of Neuroscience, Department of Neurophysiology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.

出版信息

J Neurol. 2017 May;264(5):1011-1014. doi: 10.1007/s00415-017-8462-7. Epub 2017 Mar 23.

DOI:10.1007/s00415-017-8462-7
PMID:28337614
Abstract
摘要

相似文献

1
Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases.利妥昔单抗治疗难治性慢性炎性脱髓鞘性多发性神经根神经病：4例报告
J Neurol. 2017 May;264(5):1011-1014. doi: 10.1007/s00415-017-8462-7. Epub 2017 Mar 23.
2
Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy.利妥昔单抗治疗儿童起病的特发性难治性慢性炎症性脱髓鞘性多发性神经病。
Eur J Paediatr Neurol. 2012 May;16(3):301-3. doi: 10.1016/j.ejpn.2011.08.002. Epub 2011 Sep 7.
3
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.利妥昔单抗治疗难治性慢性炎症性脱髓鞘性多发性神经病。
Muscle Nerve. 2020 May;61(5):575-579. doi: 10.1002/mus.26804. Epub 2020 Jan 21.
4
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.利妥昔单抗治疗慢性炎症性脱髓鞘性多发神经病：13 例报告及文献复习
J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):306-8. doi: 10.1136/jnnp.2009.188912. Epub 2010 Jul 16.
5
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.难治性慢性炎症性脱髓鞘性多发性神经根神经病的免疫抑制治疗。一项全国性回顾性分析。
Eur J Neurol. 2011 Dec;18(12):1417-21. doi: 10.1111/j.1468-1331.2011.03495.x. Epub 2011 Aug 5.
6
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.用于慢性炎症性脱髓鞘性多发性神经根神经病的细胞毒性药物和干扰素。
Cochrane Database Syst Rev. 2003(1):CD003280. doi: 10.1002/14651858.CD003280.
7
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.利妥昔单抗治疗常规免疫治疗反应不佳的慢性炎症性脱髓鞘性多发神经病的前瞻性开放标签试验。
J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):838-844. doi: 10.1136/jnnp-2023-332844.
8
Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.一名8岁女孩患慢性炎症性脱髓鞘性多发性神经根神经病，并伴有耳聋和肾纤维化。
J Child Neurol. 2009 Aug;24(8):997-1000. doi: 10.1177/0883073808331353. Epub 2009 Feb 23.
9
[Chronic inflammatory demyelinating polyradiculoneuropathy].[慢性炎性脱髓鞘性多发性神经根神经病]
Rev Med Interne. 2010 Jun;31(6):411-6. doi: 10.1016/j.revmed.2009.08.006. Epub 2010 Apr 14.
10
Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura.利妥昔单抗在与特发性血小板减少性紫癜相关的慢性炎症性脱髓鞘性多发性神经病中的疗效。
Muscle Nerve. 2008 Aug;38(2):1076-7. doi: 10.1002/mus.21073.

引用本文的文献

1
Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study.难治性慢性炎性脱髓鞘性多发性神经病的见解：一项全面的真实世界研究。
Front Neurol. 2024 Jan 31;15:1326874. doi: 10.3389/fneur.2024.1326874. eCollection 2024.
2
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.利妥昔单抗治疗自身免疫性甲状腺疾病的有效性和安全性：一项单中心队列研究。
J Neurol. 2023 Sep;270(9):4288-4295. doi: 10.1007/s00415-023-11759-2. Epub 2023 May 17.
3
Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.

本文引用的文献

1
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.利妥昔单抗治疗针对连接蛋白抗体阳性的难治性 CIDP。
Neurol Neuroimmunol Neuroinflamm. 2015 Sep 3;2(5):e149. doi: 10.1212/NXI.0000000000000149. eCollection 2015 Oct.
2
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.慢性炎症性脱髓鞘性多发性神经根神经病：从病理到表型
J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85. doi: 10.1136/jnnp-2014-309697. Epub 2015 Feb 12.
3
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
利妥昔单抗治疗慢性炎症性脱髓鞘性多发性神经病的疗效：系统评价和荟萃分析。
J Neurol. 2022 Mar;269(3):1250-1263. doi: 10.1007/s00415-021-10646-y. Epub 2021 Jun 12.
4
Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study.环磷酰胺、利妥昔单抗和硼替佐米对慢性免疫介导性感觉运动性神经病的治疗反应：一项回顾性队列研究。
Ther Adv Neurol Disord. 2021 Mar 5;14:1756286421999631. doi: 10.1177/1756286421999631. eCollection 2021.
5
Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy.慢性炎症性脱髓鞘性多发性神经病的诊断、监测及治疗综合方法
Neurol Res Pract. 2020 Dec 8;2:42. doi: 10.1186/s42466-020-00088-8. eCollection 2020.
6
Complement in neurological disorders and emerging complement-targeted therapeutics.神经疾病中的补体及新兴的补体靶向疗法。
Nat Rev Neurol. 2020 Nov;16(11):601-617. doi: 10.1038/s41582-020-0400-0. Epub 2020 Oct 1.
7
Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial.利妥昔单抗治疗伴或不伴IgG4自身抗体的难治性慢性炎性脱髓鞘性多发性神经病的疗效和安全性（RECIPE）：一项双盲、随机、安慰剂对照临床试验方案
JMIR Res Protoc. 2020 Apr 1;9(4):e17117. doi: 10.2196/17117.
8
Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy.芬戈莫德治疗对自发性自身免疫性周围多发性神经病的小鼠模型无效。
Sci Rep. 2018 Apr 4;8(1):5648. doi: 10.1038/s41598-018-23949-4.
脱髓鞘疾病中Ranvier 结处的自身免疫性抗原靶标。
Nat Rev Neurol. 2015 Mar;11(3):143-56. doi: 10.1038/nrneurol.2014.260. Epub 2015 Jan 27.
4
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.除皮质类固醇、免疫球蛋白和血浆置换外，用于慢性炎性脱髓鞘性多发性神经根神经病的免疫调节治疗
Cochrane Database Syst Rev. 2013 Jun 14(6):CD003280. doi: 10.1002/14651858.CD003280.pub4.
5
Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era.儿童慢性炎症性脱髓鞘性多发性神经病：现代10例病例概述
J Child Neurol. 2014 Jan;29(1):43-8. doi: 10.1177/0883073812471719. Epub 2013 Jan 29.
6
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.红斑狼疮性系统性多神经根炎伴慢性炎症性脱髓鞘性多发性神经病，利妥昔单抗治疗后预后良好。
Rheumatol Int. 2012 Dec;32(12):4061-3. doi: 10.1007/s00296-011-2130-5. Epub 2011 Sep 16.
7
Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy.利妥昔单抗治疗儿童起病的特发性难治性慢性炎症性脱髓鞘性多发性神经病。
Eur J Paediatr Neurol. 2012 May;16(3):301-3. doi: 10.1016/j.ejpn.2011.08.002. Epub 2011 Sep 7.
8
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.难治性慢性炎症性脱髓鞘性多发性神经根神经病的免疫抑制治疗。一项全国性回顾性分析。
Eur J Neurol. 2011 Dec;18(12):1417-21. doi: 10.1111/j.1468-1331.2011.03495.x. Epub 2011 Aug 5.
9
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.利妥昔单抗治疗慢性炎症性脱髓鞘性多发神经病：13 例报告及文献复习
J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):306-8. doi: 10.1136/jnnp.2009.188912. Epub 2010 Jul 16.
10
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision.欧洲神经病学会联合会/周围神经学会关于慢性炎症性脱髓鞘性多发性神经病管理指南：欧洲神经病学会联合会和周围神经学会联合工作组的报告——第一次修订版。
J Peripher Nerv Syst. 2010 Mar;15(1):1-9. doi: 10.1111/j.1529-8027.2010.00245.x.